Corcept Therapeutics reported $16.6M in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -41725000 14.54M
Ani Pharmaceuticals ANIP:US USD -4243000 4.36M
Ardelyx ARDX:US USD 10.7M 33.59M
Aurora Cannabis Inc ACB:CN CAD -65392000 13.79M
Biomarin Pharmaceutical BMRN:US USD -249000 6.4M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Canopy Growth Corp WEED:CN CAD -261583000 39.78M
Corcept Therapeutics CORT:US USD 16.6M 18.01M
Eli Lilly And LLY:US USD 1.94B 486M
Esperion Therapeutics ESPR:US USD -55487000 370K
Johnson & Johnson JNJ:US USD 3.52B 938M
Knight Therapeutics Inc GUD:CN CAD 1.59M 925K
Lexicon Pharmaceuticals LXRX:US USD -30494000 7.11M
Merk MRK:US USD 3.02B 231M
Nektar Therapeutics NKTR:US USD -59688000 639K
Novartis NOVN:VX USD 1.47B 107M
Novartis NVS:US USD 1.47B 107M
Pacira Pharmaceuticals PCRX:US USD -10102000 9.41M
Pfizer PFE:US USD 5B 3.61B
Supernus Pharmaceuticals SUPN:US USD 25.48M 23.73M
Tg Therapeutics TGTX:US USD -52994000 17.18M
Ziopharm Oncology ZIOP:US USD -9159000 308K